Q4 2009

Source filing unavailable

Q4 2009 · —

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived$115,722,000—

Free Cash Flowderived$96,609,000—

Same quarter

no prior Q4 2008 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR